Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Markus Renschler Insider Profile
4 Followers
Markus Renschler, Sr. VP, Oncology Clinical Dev at Pharmacyclics, holds 1.39K shares in Pharmacyclics (Ticker: PCYC), holds 1.10M shares in Cyteir Therapeutics (Ticker: CYT). Most recently, Markus Renschler ― shares of Pharmacyclics on ― for an estimated value of ―.
Markus Renschler Pharmacyclics (PCYC)Sr. VP, Oncology Clinical Dev
Pharmacyclics (PCYC)
Sr. VP, Oncology Clinical Dev
Not Ranked
Markus Renschler has not reported sufficient informative transactions and therefore cannot be ranked.
Time Frame
Compare to
Insider Holdings
Markus Renschler does not currently own shares as a corporate insider.
A breakdown of Markus Renschler's holdings
Insider Roles
Markus Renschler does not currently hold a role as a corporate insider.
Roles that Markus Renschler holds in companies
Most Profitable Insider Trade
Currently, no data available
The most profitable trade made by Markus Renschler
Markus Renschler's Trading History
Pharmacyclics
―
―
―
―
Cyteir Therapeutics
Feb 07, 2023
―
Uninformative Buy
7.45K
$3.32M
List of latest transactions for each holding click on a transaction to see Markus Renschler's performance on stock
You May Also Like
Markus Renschler insider profile FAQ
What is the percentage of profitable transactions made by Markus Renschler?
The percentage of profitable transactions made by Markus Renschler is ―.
What is the average return per transaction made by Markus Renschler?
The average return per transaction made by Markus Renschler is ―.
What stocks does Markus Renschler hold?
Markus Renschler holds: PCYC, CYT stocks.
What was Markus Renschler’s latest transaction?
Markus Renschler latest transaction was an Uninformative Buy of ―.
What was Markus Renschler's most profitable transaction?
Markus Renschler’s most profitable transaction was an Uninformative Buy of stock on ―. The return on the trade was ―.
What is Markus Renschler's role in Pharmacyclics?
Markus Renschler's role in Pharmacyclics is Sr. VP, Oncology Clinical Dev.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.